Tesla UK Car Sales Slump 29% in December as Chinese Brands Gain Ground Reuters $Tesla Motors(TSLA)$ 19:08 (Reuters) - Tesla's UK car registrations dropped by more than 29% year-on-year in December, industry data showed on Tuesday, underscoring the intense competition from Chinese rivals faced by the U.S. electric vehicle maker in its largest European market. The Elon Musk-led company's UK registrations - a proxy for sales - fell to 6,323 units last month, according to New AutoMotive data. For 2025, Tesla's UK sales fell 8.9% year-on-year. The drop echoed trends seen in other European markets, where Tesla sales have suffered due to competition, an ageing lineup and Musk's political stance in Europe. In contrast
Massive day for Nvidia as it officially kicks off the CES 20
Today, January 5, 2026, is a massive day for Nvidia as it officially kicks off the CES 2026 tech show in Las Vegas. The company is currently the world’s most valuable publicly traded firm, with a market cap hovering around $4.6 trillion. $NVIDIA(NVDA)$ Here are the most critical updates for Nvidia today: 1. CES 2026 Keynote (Happening Today) CEO Jensen Huang is delivering a 90-minute keynote at 4:00 PM ET today. The focus has shifted from just "chips" to "Physical AI"—the idea of AI moving from the screen into the real world. Vera Rubin Architecture: Investors are watching for more details on the "Rubin" chips (the successor to Blackwell), which are slated to ship in the second half of 2026. Robotics Takeover: Nvidia is showcasing over 20
Bezos, Catz, Dell Lead 2025's Top Insider Sellers with Billions Cashed Out Trading Random $Amazon.com(AMZN)$ $Meta Platforms, Inc.(META)$ $Nutanix Inc.(NTNX)$ In 2025, mega-cap technology corporations disproportionately fueled the US stock market's ascent, while their executives similarly dominated insider selling activity. Billionaire founders, chief executives, and directors collectively liquidated over $16 billion worth of shares. The most substantial transaction originated from Amazon.com Inc.'s Jeff Bezos, who initiated stock sales coinciding with his celebrity-filled wedding to Lauren Sanchez. The eventual disposal of 25 million Ama
Nvidia Shares Rise 2% After the Company Agrees to License Chip Technology From Startup Groq $NVIDIA(NVDA)$ NVIDIA has entered into a nonexclusive licensing agreement with AI-chip maker Groq, and will acquire some of the startup’s executive team. Nvidia’s stock rose 2% in Friday trading. In a blog post on Wednesday, Groq said founder and CEO Jonathan Ross, President Sunny Madra and other personnel will be joining Nvidia “to help advance and scale” the licensed inference technology. “The agreement reflects a shared focus on expanding access to high-performance, low-cost inference,” Groq said. Earlier, CNBC had reported Nvidia was buying Groq outright for about $20 billion, citing Alex Davis, CEO of investment fi
Reassessing Sea (NYSE:SE) Valuation After Strong Q
Reassessing Sea Valuation After Strong Quarterly Results and New Share Buyback Program $Sea Ltd(SE)$ Simply Wall St Reviewed by Simply Wall St December 21, 2025 Share Copy Link Sea (NYSE:SE) just dropped a quarterly update that checked two big boxes for investors: healthier profits and cash flow, plus a sizable share buyback that underlines management’s confidence despite ongoing competitive and margin pressure. See our latest analysis for Sea. Even with this stronger quarter, Sea’s 30 day share price return of minus 7.13 percent and 90 day share price return of minus 36.79 percent show momentum has cooled. At the same time, a 3 year total shareholder return of 144.33 percent signals the longer term growth story
Gold prices hit record high above $4,500/oz on haven demand, Fed easing bets $Gold.com(GOLD)$ $ETFS Physical Gold(GOLD)$ $Gold.com(GOLD)$ $Silver - main 2603(SImain)$ $Copper - main 2603(HGmain)$ Investing.com-- Gold prices climbed above $4,500 an ounce for the first time on Wednesday, extending a historic rally as investors sought safe havens amid heightened geopolitical tensions and firm expectations that the U.S. Federal Reserve will cut interest rates further next year. The move was amplified by thin liquidity in a holiday-
Nvidia aims to begin H200 chip shipments to China by mid-Feb
Nvidia $NVIDIA(NVDA)$ has told Chinese clients it aims to start shipping its second-most powerful AI chips to China before the Lunar New Year holiday in mid-February, three people familiar with the matter told Reuters. The U.S. chipmaker plans to fulfil initial orders from existing stock, with shipments expected to total 5,000 to 10,000 chip modules — equivalent to about 40,000 to 80,000 H200 AI chips, the first and second sources said. Nvidia has also told Chinese clients that it plans to add new production capacity for the chips, with orders for that capacity opening in the second quarter of 2026, the third source said. Significant uncertainty remains, as Beijing has yet to approve any H200 purchases and the timeline could s
Nvidia stock gains on Trump chip export review, sparking rally in chipmakers $NVIDIA(NVDA)$ Nvidia stock (NVDA) rose 3.6% on Friday following a Reuters report that the Trump administration began its review of Nvidia H200 chip exports to China and news that US antitrust agencies cleared Nvidia's investment into Intel (INTC). The move higher put shares of the world's largest company on track for a weekly gain, as investors viewed the news as a sign that President Trump would follow through on his promise to allow Nvidia to sell advanced chips to China in exchange for a 25% fee to the governmen According to Reuters, the US Commerce Department sent license applications for the sale of Nvidia's advanced chips to the State, Energy, and Defense
Nine of the largest pharma companies ink deals with Trump to
Key Points Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation’s drug prices to cheaper ones abroad. Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk have already struck deals with the Trump administration to cut prices. In exchange, the companies agreed to a three-year grace period during which their products won’t face Trump’s planned pharmaceutical-specific tariffs — as long as the drugmakers further invest in U.S. manufacturing. Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump on Friday to voluntarily sell their medications for less, as his administration pushes to link the nation’s drug prices t